MyFinsight
Home
Blog
About
Cash and cash
equivalents
$545,683K
(3.92%↑ Y/Y)
Other current assets
$29,321K
(-21.47%↓ Y/Y)
Other receivables
$14,393K
(-33.38%↓ Y/Y)
Prepaid data assets
$8,680K
Restricted cash
$5,385K
(73.37%↑ Y/Y)
Total current assets
$603,462K
(2.78%↑ Y/Y)
Intangible assets, net
$282,888K
(-17.12%↓ Y/Y)
Goodwill
$160,350K
(-2.39%↓ Y/Y)
Property and equipment,
net
$89,623K
(-25.34%↓ Y/Y)
Operating lease
right-of-use assets
$40,271K
(-19.98%↓ Y/Y)
Financing lease
right-of-use assets
$17,179K
(-26.09%↓ Y/Y)
Other assets,
non-current
$12,186K
(29.42%↑ Y/Y)
Restricted cash,
non-current
$5,752K
(2.19%↑ Y/Y)
Deferred tax assets
$957K
(0.00%↑ Y/Y)
Total assets
$1,212,668K
(-6.89%↓ Y/Y)
Total liabilities and
stockholders equity
$1,212,668K
(-6.89%↓ Y/Y)
Total stockholders
equity
$915,003K
(-0.45%↓ Y/Y)
Total liabilities
$297,665K
(-22.32%↓ Y/Y)
Accumulated deficit
-$2,324,511K
(-28.74%↓ Y/Y)
Additional paid-in capital
$3,211,515K
(19.78%↑ Y/Y)
Total current
liabilities
$119,886K
(-26.91%↓ Y/Y)
Unearned revenue,
non-current
$112,818K
(-10.63%↓ Y/Y)
Operating lease
liabilities, non-current
$39,193K
(-26.60%↓ Y/Y)
Deferred tax liabilities
$18,313K
(-23.00%↓ Y/Y)
Notes payable and
financing lease...
$4,753K
(-66.52%↓ Y/Y)
Other liabilities,
non-current
$2,702K
(72.65%↑ Y/Y)
Accumulated other
comprehensive income
$27,994K
(-35.82%↓ Y/Y)
Common stock, 0.00001
par value...
$5K
(25.00%↑ Y/Y)
Accrued expenses and
other liabilities
$56,936K
(-11.43%↓ Y/Y)
Unearned revenue
$27,586K
(-30.50%↓ Y/Y)
Operating lease
liabilities
$13,249K
(12.93%↑ Y/Y)
Accounts payable
$12,672K
(-34.39%↓ Y/Y)
Notes payable and
financing lease...
$9,443K
(7.90%↑ Y/Y)
Back
Back
Balance Sheet
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)
source: myfinsight.com